ISCHEMIA trial hailed as practice changing
The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics
Further analyses from the DAPA-HF trial showed dapagliflozin cut death and heart failure events in HFrEF patients with no diabetes.
The TWILIGHT of aspirin post-PCI for ACS?
Patients do better post-PCI for non-ST-elevation ACS with ticagrelor monotherapy
Weaknesses exposed in valsartan recall
ED visits for hypertension in month after the 2018 recall spiked 55%
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets
DOJ lawsuit reins in inappropriate ICD use
Amplatzer slashes stroke risk in high-risk AF patients
How NIH scientists corrupted a large alcohol study
USPSTF drops ECG for low-risk patients
Botox, PVCs, and statins
Big surprises from EuroPCR
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive